Study shows lasting benefits of weight loss and diabetes remission for the heart and kidneys

Researchers in the School of Population Health at RCSI University of Medicine and Health Sciences have provided new evidence of the health benefits of weight loss efforts that lead to diabetes remission for type 2 diabetes patients.

Maternal cannabis use disorder linked to higher autism risk in children, study finds

A study in Psychiatry Research reveals that maternal cannabis use disorder significantly increases the risk of autism spectrum disorder (ASD) in offspring. The risk is

May 23, 2024

Researchers develop machine learning-based tool for assessment of shoulder function

A study published in Scientific Reports introduces a simple string-pulling task as a reliable method for assessing shoulder mobility in both animals and humans. This

November 20, 2023

Clearmind Medicine : FDA approval for the IND submission to conduct its trial already secured Form 6K | Psychedelic Invest

Vancouver, Canada, Oct. 10, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on

October 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.